SARS-CoV-2/COVID-19 Toolbox

Mollie WO, et al.
Infants with in utero COVID-19 exposure vs controls exhibited differential trajectories of weight and BMI.

Martínez-Colón GJ, Ratnasiri K, et al.
Authors state that the data suggest that SARS-CoV-2 infection of adipose tissue could contribute to COVID-19 severity through replication of virus within adipocytes and through induction of local and systemic inflammation driven by infection of adipose tissue-resident macrophages.

Kuodi, P., Gorelik, Y., Zayyad, H. et al.
Vaccination with at least two doses of COVID-19 vaccine was associated with a substantial decrease in reporting the most common post-acute COVID-19 symptoms, bringing it back to baseline. Our results suggest that, in addition to reducing the risk of acute illness, COVID-19 vaccination may have a protective effect against long COVID.

Rathnasinghe R, Jangra S, Miorin L, et al.

Hanson KE, Goddard K, Lewis N, et al.

Surveillance data from the Vaccine Safety Datalink showed increased incidence rate of confirmed GBS 1 to 21 days after receiving the Ad.26.COV2.S (Janssen).

Delpuech O, Douthwaite JA, Hill T, et al.
Heating as the sole method of virus inactivation is ideally suited to streamlined and more rapid workflows such as ‘direct to PCR’ assays that do not involve RNA extraction or chemical neutralisation methods.

Wang R, et.al

Su Y, et. al

The study found four factors that could be identified early in a person’s coronavirus infection that appeared to correlate with increased risk of having lasting symptoms weeks later.

Lui, DT, et. al
Literature review of thyroid dysfunction after SARS-CoV-2 vaccination.

Antia R, Halloran ME

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, coronavirus disease 2019 (COVID-19), has caused a devastating pandemic worldwide. Here, we explain basic concepts underlying the transition from an epidemic to an endemic state, where a pathogen is stably maintained in a population. We discuss how the number of infections and the severity of disease change in the transition from the epidemic to the endemic phase and consider the implications of this transition in the context of COVID-19.

Warmbrod, K. et al.

Improving biosafety measures requires a more precise definition of which experiments would raise safety concerns

Farinholt T, Doddapaneni H, Qin X, et al.
The authors say “Our observations support continued efforts to generate SARS-CoV-2 genomic sequences from positive patient samples, to identify possible vaccine breakthrough mutations.”

Lindsley WG, et al.
The authors studied the source control performance of 15 cloth masks, two medical masks, and two N95 filtering facepiece respirators by measuring their ability to block aerosols < or = to 7 micrometers

Mathieu E, Ritchie H, Ortiz-Ospina E, et al.

Sowerby L J, Nichols A C, Gibson R, et al.

Meister T L, Fortmann J, Todt D, et al.

Morawska L, et al.

Saunders, K.O., Lee, E., Parks, R. et al.

Boyarski B, Werbel W, Avery R, et al.

Sewage epidemiology has been embraced in other countries for decades, but not in the U.S. Will Covid change that?

Agency says end of mask shortages means less need for alternative policies.

Springer Nature is making SARS-CoV-2 and COVID-19 research free.

Browse the JAMA Network COVID-19 collection, including Q&A’s with NIAID’s Anthony Fauci and Patient Information pages.

Free Medical, Social, and Behavioral Science Articles from SAGE Publishing

To support the continued growth and rapid development of research around the world during the COVID-19 pandemic, we have collected all of our relevant academic resources to inform and provide opportunities within the fields of coronavirus research, viral immunology, telemedicine, and public health crises. All articles below are available freely online.

Elsevier’s free health and medical research on novel coronavirus (COVID-19)

To assist health workers and researchers working under challenging conditions to bring this outbreak to a close, The Lancet has created a Coronavirus Resource Centre. This resource brings together new 2019 novel coronavirus disease (COVID-19) content from across the Lancet journals as it is published. All of our COVID-19 content is free to access.

Liang M, et al.

Alfson KJ, Griffiths A.

Loibner M, et al.

Möller, Lars et al.

Pastorino, Boris et al.

Darnell ME, Subbarao K, et al.

The virus was inactivated by ultraviolet light (UV) at 254 nm, heat treatment of 65 ◦C or greater, alkaline (pH > 12) or acidic (pH < 3) conditions, formalin and glutaraldehyde treatments.

Jianhui N, et al.

Pastorino B, et al.

Odega K, et al.

Ahmad T, et al.

Tara Oberg, et al.

Surgical masks have been used since the early 1900s to minimize infection of surgical wounds from wearer-generated bacteria. There is ongoing debate, however, whether surgical masks can meet the expectations of respiratory protection devices. The goal of this study was to evaluate the filter performance and facial fit of a sample of surgical masks.

C. MacIntyre, A. Chughtai

A systematic review of randomized controlled clinical trials on use of respiratory protection by healthcare workers, sick patients and community members was conducted.

Wang X, Ferro EG, Zhou G, et al.

Wang X, Ferro EG, Zhou G, et al.

Degesys NF, Wang RC, et al.

B Atkinson, E Petersen

P Iwen, K Stiles, M Pentella,

Kalish H, et al.
The authors measured antibody prevalence in study participants who had not previously been diagnosed with a SARS-CoV-2 infection during the first wave of the COVID-19 pandemic

Xiling, G., Yin, C., Ling, W. et al.
“we used a sequenced SARS-CoV-2 strain from an infected person in Jiangsu, China, to evaluate the inactivation effect of commonly used disinfection methods on SARS-CoV-2. We tested the effect of chlorine-containing disinfectants, two kinds of QAC named Di-N-decyl dimethyl ammonium bromide (DNB) and Di-N-decyl dimethyl ammonium chloride (DNC), ethanol, and heat on SARS-CoV-2 inactivation, to provide important information on their efficiency on virus inactivation.”

Warmbrod, K. et al.

Improving biosafety measures requires a more precise definition of which experiments would raise safety concerns

Liang M, et al.

Lindsley WG, et al.
The authors studied the source control performance of 15 cloth masks, two medical masks, and two N95 filtering facepiece respirators by measuring their ability to block aerosols < or = to 7 micrometers

Liang M, et al.

Tara Oberg, et al.

Surgical masks have been used since the early 1900s to minimize infection of surgical wounds from wearer-generated bacteria. There is ongoing debate, however, whether surgical masks can meet the expectations of respiratory protection devices. The goal of this study was to evaluate the filter performance and facial fit of a sample of surgical masks.

C. MacIntyre, A. Chughtai

A systematic review of randomized controlled clinical trials on use of respiratory protection by healthcare workers, sick patients and community members was conducted.

Meister T L, Fortmann J, Todt D, et al.

Morawska L, et al.

Odega K, et al.

Ahmad T, et al.

Rathnasinghe R, Jangra S, Miorin L, et al.

Delpuech O, Douthwaite JA, Hill T, et al.
Heating as the sole method of virus inactivation is ideally suited to streamlined and more rapid workflows such as ‘direct to PCR’ assays that do not involve RNA extraction or chemical neutralisation methods.

Alfson KJ, Griffiths A.

Loibner M, et al.

Möller, Lars et al.

Pastorino, Boris et al.

Darnell ME, Subbarao K, et al.

The virus was inactivated by ultraviolet light (UV) at 254 nm, heat treatment of 65 ◦C or greater, alkaline (pH > 12) or acidic (pH < 3) conditions, formalin and glutaraldehyde treatments.

Jianhui N, et al.

Pastorino B, et al.

Xiling, G., Yin, C., Ling, W. et al.
“we used a sequenced SARS-CoV-2 strain from an infected person in Jiangsu, China, to evaluate the inactivation effect of commonly used disinfection methods on SARS-CoV-2. We tested the effect of chlorine-containing disinfectants, two kinds of QAC named Di-N-decyl dimethyl ammonium bromide (DNB) and Di-N-decyl dimethyl ammonium chloride (DNC), ethanol, and heat on SARS-CoV-2 inactivation, to provide important information on their efficiency on virus inactivation.”

Kuodi, P., Gorelik, Y., Zayyad, H. et al.
Vaccination with at least two doses of COVID-19 vaccine was associated with a substantial decrease in reporting the most common post-acute COVID-19 symptoms, bringing it back to baseline. Our results suggest that, in addition to reducing the risk of acute illness, COVID-19 vaccination may have a protective effect against long COVID.

Wang R, et.al

Su Y, et. al

The study found four factors that could be identified early in a person’s coronavirus infection that appeared to correlate with increased risk of having lasting symptoms weeks later.

Farinholt T, Doddapaneni H, Qin X, et al.
The authors say “Our observations support continued efforts to generate SARS-CoV-2 genomic sequences from positive patient samples, to identify possible vaccine breakthrough mutations.”

Meister T L, Fortmann J, Todt D, et al.

Morawska L, et al.

Kalish H, et al.
The authors measured antibody prevalence in study participants who had not previously been diagnosed with a SARS-CoV-2 infection during the first wave of the COVID-19 pandemic

Antia R, Halloran ME

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, coronavirus disease 2019 (COVID-19), has caused a devastating pandemic worldwide. Here, we explain basic concepts underlying the transition from an epidemic to an endemic state, where a pathogen is stably maintained in a population. We discuss how the number of infections and the severity of disease change in the transition from the epidemic to the endemic phase and consider the implications of this transition in the context of COVID-19.

Farinholt T, Doddapaneni H, Qin X, et al.
The authors say “Our observations support continued efforts to generate SARS-CoV-2 genomic sequences from positive patient samples, to identify possible vaccine breakthrough mutations.”

Sowerby L J, Nichols A C, Gibson R, et al.

Boyarski B, Werbel W, Avery R, et al.

L Chang, Y Yan, L Wang

P Iwen, K Stiles, M Pentella,

Martínez-Colón GJ, Ratnasiri K, et al.
Authors state that the data suggest that SARS-CoV-2 infection of adipose tissue could contribute to COVID-19 severity through replication of virus within adipocytes and through induction of local and systemic inflammation driven by infection of adipose tissue-resident macrophages.